Company Filing History:
Years Active: 2008
Title: Jinwan Wang: Innovator in Cancer Treatment
Introduction
Jinwan Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on utilizing modified proteins to combat angiogenesis-related diseases.
Latest Patents
Jinwan Wang holds a patent for "Methods of treating cancer using a modified endostatin protein." This invention provides methods for treating angiogenesis-related diseases by using a therapeutically effective amount of a modified endostatin protein. The methods include combining the modified endostatin with known cancer therapy agents, such as chemotherapy or radiotherapy agents.
Career Highlights
Wang is currently associated with Medgenn (Hong Kong) Ltd., where he continues to advance his research in cancer therapies. His dedication to improving treatment options for patients has positioned him as a key figure in the medical research community.
Collaborations
He collaborates with notable colleagues, including Yongzhang Luo and Zhuobing Zhang, who contribute to his research efforts and help drive innovation in cancer treatment.
Conclusion
Jinwan Wang's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His patented methods represent a significant advancement in therapeutic strategies, showcasing the potential of modified proteins in combating serious diseases.